Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery
Contrast-Enhanced Breast MRI, MRS, And Correlative Science Studies To Characterize Tumor Response In Patients Undergoing Neoadjuvant Treatment For Locally Advanced Breast Cancer
Sponsor: Alliance for Clinical Trials in Oncology
A observational or N/A phase clinical study on Breast Cancer, this trial is completed. The trial is conducted by Alliance for Clinical Trials in Oncology and has accumulated 8 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 3 earlier versions
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Chapel Hill, United States
- • Chicago, United States
- • Minneapolis, United States
- • New York, United States
- • San Francisco, United States